These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2665869)

  • 61. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
    Budde U; Schneppenheim R
    Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thrombocytopenic purpura and cardiomyopathy in pregnancy reversed by combined plasma exchange and infusion.
    Cosmai EM; Puzis L; Tsai HM; Lian EC
    Eur J Haematol; 2002 Apr; 68(4):239-42. PubMed ID: 12071941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
    Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?
    Zipfel PF; Wolf G; John U; Kentouche K; Skerka C
    Pediatr Nephrol; 2011 Nov; 26(11):1947-56. PubMed ID: 21671028
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers.
    Rowe JM; Francis CW; Cyran EM; Marder VJ
    Am J Hematol; 1985 Oct; 20(2):161-8. PubMed ID: 3876029
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Von Willebrand factor regulates complement on endothelial cells.
    Noone DG; Riedl M; Pluthero FG; Bowman ML; Liszewski MK; Lu L; Quan Y; Balgobin S; Schneppenheim R; Schneppenheim S; Budde U; James P; Atkinson JP; Palaniyar N; Kahr WH; Licht C
    Kidney Int; 2016 Jul; 90(1):123-34. PubMed ID: 27236750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Controversies in differentiating thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Shah NT; Rand JH
    Mt Sinai J Med; 2003 Oct; 70(5):344-51. PubMed ID: 14631521
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Tersteeg C; Roodt J; Van Rensburg WJ; Dekimpe C; Vandeputte N; Pareyn I; Vandenbulcke A; Plaimauer B; Lamprecht S; Deckmyn H; Lopez JA; De Meyer SF; Vanhoorelbeke K
    Blood; 2017 Feb; 129(8):1030-1038. PubMed ID: 28011677
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.
    Moake J
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):567-76. PubMed ID: 19959109
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.
    Bell WR; Braine HG; Ness PM; Kickler TS
    N Engl J Med; 1991 Aug; 325(6):398-403. PubMed ID: 2062331
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.
    Manea M; Karpman D
    Pediatr Nephrol; 2009 Mar; 24(3):447-58. PubMed ID: 18807073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
    Fujimura Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
    [No Abstract]   [Full Text] [Related]  

  • 78. [Hemolytic uremic syndrome (HUS): pathophysiology--with reference to the differentiation between HUS and thrombotic thrombocytopenic purpura].
    Naruse T
    Nihon Rinsho; 1993 Jan; 51(1):187-92. PubMed ID: 8433517
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
    Katagiri H; Kawai Y; Sugizaki N; Sakai K; Handa M; Okamoto S; Watanabe K
    Rinsho Byori; 2003 Jun; 51(6):516-21. PubMed ID: 12884737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.